RICCHETTI INCORPORATED for ELI LILLY AND COMPANY
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 15, 2009 | $50,000 | Replaced |
| 4th Quarter - Report | Jul 16, 2010 | $50,000 | Replaced |
| 4th Quarter - Amendment (this page) | Jul 17, 2010 | $50,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Advertising ADV
issues relating to direct-to-consumer advertising of prescription drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFF RICCHETTI | — |
Copyright/Patent/Trademark CPT
issues related to proposed reform of the US patent system (Patent Reform Act S 1145, H.R. 1908)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFF RICCHETTI | — |
Health Issues HCR
issues pertaining to the importation of prescription drugs issues relating to the approval of follow-on biologics issues relating to cancer research issues relating to mental health parity issues related to drug safety legislation issues related to disclosure of company gifts issues related to multi-drug resistant tuberculosis
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFF RICCHETTI | — |
Medicare/Medicaid MMM
issues related to the pharmaceutical reimbursement in HR 6331 (Medicare Improvements for Patients and Providers Act) issues relating to comparative effectiveness research issues relating to the use of tamper resistant Rx pads issues relating to the registry of education grant funding issues relating to Medicaid rebates
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFF RICCHETTI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.